Short answer
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $743M (up 55.6% year over year) with net income of $28M.
Q2 2026 key financials · XBRL
- Revenue
- $743M
- +55.6% YoY · −0.8% QoQ
- Net income
- $28M
- +401.0% YoY · +2.4% QoQ
- Operating margin
- 3.8%
- EPS (diluted)
- $0.05
- +0.0% QoQ
Source: XBRL data from the CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) Q2 2026 10-Q on SEC EDGAR. USD.
CLOVER HEALTH INVESTMENTS, CORP. /DE Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $743.2M, up 55.6% YoY from $477.6M, driven by 49% membership growth
- Net income $28.0M vs $10.6M loss YoY; operating margin 3.8% vs negative 2.2%
- PPO plans’ premiums earned $737.8M, up 57%; Insurance benefits ratio 87.6% vs 88.4% YoY
- Adjusted SG&A margin 15.1% vs 17.3%; quarterly Adjusted EBITDA $40.9M vs $17.1M
- Cash, cash equivalents, and investments $443.0M at June 30; 2027 payment outlook supported by 4.5-Star PPO and HMO ratings
Risk Factors
- No material changes disclosed from Item 1A of the 2025 Form 10-K
- Carried-forward risk disclosures may adversely affect business, financial condition, and results of operations
- Multiple risk factors could materially reduce Class A common stock market price
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CLOVER HEALTH INVESTMENTS, CORP. /DE quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.